CLARI.PA Clariane SE

Healthcare Health Care Providers & Services Euronext Paris
3.48 EUR
Close of Nov 8, 2026
2.98 4.42
Market cap
EUR 1.24B
P/E
116.1x
P/B
0.34x
ROE
-5.3%
Dividend yield
5.62%
Fundamental score
0.0/5

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.

Is CLARI.PA undervalued?

Graham number
Price3.48
Graham value2.61
Premium33.2%

CLARI.PA trades 33.2% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Clariane SE fundamental analysis

0 of 11 checks passed

ROE 0/2

Unidentified ROE

ROA 0/2

Unidentified ROA

PBV 0/2

Unidentified ROA

DER 0/2

Unidentified DER

Revenue Growth 0/2

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

Net Profit Growth 0/2

Over the past five years, this company's net profit has failed to exhibit any growth, indicating a stagnant financial performance and making it a less favorable choice for potential investors.

Assets Growth 0/2

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

Graham Number 0/1

Unidentified Graham Number

Dividend Growth 0/2

The company's dividend growth has shown no improvement in the past three years, making it a less attractive investment option for those seeking increasing returns.

Dividend 0/2

No dividends from the company in the past three years raises doubts about its profitability for shareholders.

Buffet Intrinsic Value 0/1

Based on Warren Buffett's formula, the company's stock seems overpriced (0), indicating a potential drawback for investors as its market price exceeds its estimated intrinsic value.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

Clariane SE stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Clariane SE

Clariane SE provides care homes, healthcare facilities and services, and shared living solutions in France, Germany, Benelux, Italy, Spain, and the United Kingdom. It operates long-term care and short stay nursing homes. The company also provides inpatient and outpatient services, full-time hospitalization, day hospitalization, and outpatient care, and operates post-acute and rehabilitation care clinics, mental healthcare clinics, and medicine-surgery-obstetrics facilities. …

Full company profile